Evidence map›Paper›PMID 28444413›Full record

ArticleHerz2018

Cerebral dopamine neurotrophic factor protects H9c2 cardiomyocytes from apoptosis.

H Liu, C Yu, H Yu, L Zhong, Y Wang, J Liu, S Zhang, J Sun, L Duan, L Gong and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Herz, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

H LiuYuhuangding Hospital, No. 20 of Yuhuangding East Road, Yantai City, Shandong Province, China.
C YuYuhuangding Hospital, No. 20 of Yuhuangding East Road, Yantai City, Shandong Province, China.
H YuSecond People's Hospital of Zhangdian District, Zibo, Shandong Province, China.
L ZhongYuhuangding Hospital, No. 20 of Yuhuangding East Road, Yantai City, Shandong Province, China.
Y WangYuhuangding Hospital, No. 20 of Yuhuangding East Road, Yantai City, Shandong Province, China.
J LiuYuhuangding Hospital, No. 20 of Yuhuangding East Road, Yantai City, Shandong Province, China.
S ZhangYuhuangding Hospital, No. 20 of Yuhuangding East Road, Yantai City, Shandong Province, China.
J SunYuhuangding Hospital, No. 20 of Yuhuangding East Road, Yantai City, Shandong Province, China.
L DuanYuhuangding Hospital, No. 20 of Yuhuangding East Road, Yantai City, Shandong Province, China.
L GongYuhuangding Hospital, No. 20 of Yuhuangding East Road, Yantai City, Shandong Province, China. leigong27@163.com.
J YangYuhuangding Hospital, No. 20 of Yuhuangding East Road, Yantai City, Shandong Province, China. yangjun196401@163.com.
Yuhuangding Hospital · CNXian Yang Central Hospital · CN

Funding

Medical and Health Development Program of Shandong Province 2015WS0017Medical and Health Development Program of Shandong Province 2016WS0711Natural Science Foundation of Shandong Province ZR2015HM058Natural Science Foundation of Shandong Province ZR2016HM72Science and Technology Development Program of Yantai City 2015WS021Science and Technology Development Program of Yantai City 2015WS022Science and Technology Development Program of Yantai City 2015WS023Youth Research Fundation of Yuhuangding Hospital 201406
6 · The paper itself

Abstract

backgroundCerebral dopamine neurotrophic factor (CDNF) has been studied in animal models of Parkinson's disease, where it was shown to repair and protect dopamine neurons. Alongside its neurotrophic activity, it can also localize in the endoplasmic reticulum (ER) acting as an ER stress response (ERSR) protein to maintain ER homeostasis. Since ER stress plays a major role in the development and progression of cardiovascular diseases, we investigated the role of CDNF in cardiomyocytes during ER stress. MATERIAL AND

methodsInitially, the expression of CDNF was tested by treating H9c2 cells with various concentrations of tunicamycin (TM) and performing reverse-transcriptase polymerase chain reaction and Western blotting. To evaluate the overexpression of CDNF in cardiomyocytes, H9c2 cells were transfected with pcDNA-CDNF and analyzed by Western blotting and indirect immunofluorescence microscopy. The effects of CDNF on cardiomyocytes during ER stress were analyzed with CCK-8 method and TUNEL staining using cells transfected with pcDNA-CDNF or pcDNA3.1. The percentage of TUNEL-positive cells was quantified as the apoptotic level.

resultsOur results showed that CDNF protein expression can be induced by activation of ER stress in cultured cardiomyocytes. Moreover, overexpression of CDNF improved cell viability and protected cardiomyocytes from apoptosis induced by ER stress.

conclusionThe findings presented here contribute toward identifying the physiological functions of CDNF in cardiovascular diseases.

Indexed as

ApoptosisMyocytes, CardiacNerve Growth FactorsAnimalsDopamineEndoplasmic Reticulum StressDopamineNerve Growth FactorsCDNF protein, humanEndoplasmic reticulum stressMuscle cells, heartProgrammed cell deathProtein folding

Identifiers

PMID28444413
OpenAlexW2607743382

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.